Latest Security Purchase Plan News

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

EPX Limited has successfully raised nearly $295,000 through a Security Purchase Plan, supporting its recent acquisition of Wattwatchers and positioning the company for further expansion.

Greenvale Energy has raised approximately $1.05 million through a share placement to fund ongoing uranium exploration at its Oasis project, with a Security Purchase Plan also offered to shareholders.

Litchfield Minerals has identified multiple high-priority conductor targets at its Oonagalabi Project and confirmed significant manganese mineralisation at Lucy Creek, backed by strong funding to advance drilling.

Andromeda Metals has launched a $15.5 million capital raising, including a $2.5 million Security Purchase Plan, to accelerate development of its Great White Project and advance HPA production.

Andromeda Metals has raised $13 million through a placement and launched a $2.5 million Security Purchase Plan to accelerate development of its Great White and High Purity Alumina projects.

EBR Systems has secured FDA approval for its pioneering leadless WiSE CRT System and obtained key Medicare reimbursement endorsements, setting the stage for its commercial rollout. The company also completed a significant capital raise to support its market expansion.

Arena REIT reported a robust FY25 with net profit up 42% to $81.5 million, driven by rental growth and property revaluations, while raising FY26 distribution guidance by 5.5%. The Group also announced a CEO succession plan amid sustained portfolio expansion and strong capital management.

Litchfield Minerals has successfully raised $500,000 through a targeted placement and is launching a $1 million Security Purchase Plan to fund upcoming drilling campaigns and working capital needs.

Universal Biosensors reported a 44% increase in net loss to A$10.45 million for H1 2025, alongside an 11% revenue decline, raising serious going concern doubts. The company is pursuing an A$8.5 million senior secured loan and equity raise to sustain operations.

Pacific Edge Limited (ASX – PEB) has announced a securities purchase plan (SPP) aiming to raise up to NZD 5 million, contingent on shareholder approval of a prior NZD 16 million placement. The move is designed to bolster working capital amid ongoing growth initiatives.

Bio-Gene Technology Limited has announced an offer of over 95 million Placement Options to investors and its Lead Manager, contingent on shareholder approval at an upcoming extraordinary general meeting. If exercised, these options could inject approximately $3.8 million into the company.